EASL is now calling for nominations for a new Scientific Committee member to join the Governing Board. The term for this member is from July 2020 to April 2023. Please note, however, that: the following countries are excluded from this call, as they are already represented in the Scientific Commi…
PRESS RELEASE 21 European institutions join forces to tackle end-stage liver disease and liver failure with a systems medicine approach Despite a vast array of available interventions and medications, more than 1 million people die of chronic liver disease (cirrhosis) per year worldwide, when the…
Exercise retards development of liver cancer by direct effects independent of weight control in an animal model that closely resembles humans with fatty liver disease, report scientists in the Journal of Hepatology. Oxford, April 14, 2020 – Liver cancer is the fourth most common cause of cancer d…
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic. 2 April 2020 – …
Subsequent to the disruption caused by the COVID-19 pandemic, EASL and 32 other leading European medical associations – together forming the Biomedical Alliance in Europe (BioMed Alliance) – have submitted a joint statement to EU leaders. Together, we are calling for support and funding for medic…
We are delighted to announce that JHEP Reports has been accepted for indexing in PubMed Central after less than one year of publication, reflecting the high quality of the journal and the articles published. All articles published since its launch in 2019 will now be fully indexed in PubMed Centr…
EASL encourages healthcare professionals to share the EASL supported COVID-Hep registry among its networks. The registry was launched at the University of Oxford, UK in March 2020, to collect data on patients, with liver disease at any stage or liver transplants, who have also developed laborato…
A review published in Liver International journal summarises the characteristics and mechanism of liver injury caused by three highly pathogenic human coronavirus infections: severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory syndrome coronavirus (MERS‐CoV), and SAR…
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and after taking extensive advice, we have decided on a postponement to 25-28 August 2020 …
On 2 March 2020, the U.S. Preventive Services Task Force published a final recommendation statement on screening for hepatitis C virus (HCV) infection in adolescents and adults. It recommends screening all adults ages 18 to 79 for hepatitis C, regardless of their risk. The Task Force is an indepe…
